Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): Results from a randomized withdrawal trial

Journal of Sexual Medicine

Volumn 8, Issue 11, 2011, Pages 3160-3170

  Goldfischer, Evan R ^a   Breaux, Jeffery ^b   Katz, Molly ^c   Kaufman, Joel ^d   Smith, William B ^e   Kimura, Toshio ^f   Sand, Michael ^f   Pyke, Rob ^f  

^a NY State Agric Experiment Station   (United States)

^b Women Center of Zachary   (United States)

^c Katz and Kade Inc   (United States)

^d Urology Research Options   (United States)

^e UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^f BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Flibanserin; Hypoactive Sexual Desire Disorder (HSDD); Low sexual desire; Premenopausal women; Safety; Withdrawal

Indexed keywords

FLIBANSERIN; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; BACKACHE; BACTEREMIA; BEDTIME DOSAGE; CHOLELITHIASIS; CLINICAL EVALUATION; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSMENORRHEA; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; INSOMNIA; IRRITABILITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MELANOMA; MENORRHAGIA; NAUSEA; OUTCOME ASSESSMENT; OVARY CYST; PELVIC EXAMINATION; PHYSICAL EXAMINATION; PREMENOPAUSE; PRIORITY JOURNAL; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RUPTURED OVARIAN CYST; SCREENING; SEDATION; SEXUAL DISTRESS; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL SATISFACTION; SIDE EFFECT; SINUSITIS; SOMNOLENCE; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

EID: 80255138301     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02458.x     Document Type: Article

References (28)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Text revision. Washington, DC: American Psychiatric Press; 2000.
2. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009;6:1549-60.
3. Shifren JL, Johannes CB, Monz BU, Russo PA, Bennett L, Rosen R. Help-seeking behavior of women with self-reported distressing sexual problems. J Womens Health (Larchmt) 2009;18:461-8.
4. Abdolrasulnia M, Shewchuk RM, Roepke N, Granstaff US, Dean J, Foster JA, Goldstein AT, Casebeer L. Management of female sexual problems: Perceived barriers, practice patterns, and confidence among primary care physicians and gynecologists. J Sex Med 2010;7:2499-508.
5. Bachmann G. Female sexuality and sexual dysfunction: Are we stuck on the learning curve? J Sex Med 2006;3:639-45.
6. Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S. Pharmacology of flibanserin. CNS Drug Rev 2002;8:117-42.
7. Marazziti D, Palego L, Giromella A, Mazzoni MR, Borsini F, Mayer N, Naccarato AG, Lucacchini A, Cassano GB. Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain. Int J Neuropsychopharmacol 2002;5:131-40.
8. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506-33.
9. Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanserin: Possible mechanism of therapeutic action in Hypoactive Sexual Desire Disorder. J Sex Med 2011;8:15-27.
10. Thorp J, Simon J, Dattani D, Taylor L, Lesko L, Kimura T, Pyke R. Efficacy of flibanserin as a potential treatment for Hypoactive Sexual Desire Disorder in North American premenopausal women: Results from the DAISY trial. J Sex Med 2009;6(5 suppl):425.
11. Jolly E, DeRogatis L, Komer L, Katz M, Moreau M, Wunderlich G, Kimura T, Pyke R. Efficacy of flibanserin as a potential treatment for Hypoactive Sexual Desire Disorder in North American premenopausal women: Results from the VIOLET trial. J Sex Med 2009;6(5 suppl):466.
12. Jolly E, Clayton A, Thorp J, Nappi R, Kimura T, Sand M, Pyke R. Patients' perspective of efficacy of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD). J Sex Med 2010;7(3 suppl):133-4.
13. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-72.
14. DeRogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with Hypoactive Sexual Desire Disorder. J Sex Med 2008;5:357-64.
15. Beck AT, Steer RA, Brown G. Manual for Beck Depression Inventory-II. San Antonio, TX: The Psychological Corporation; 1996.
16. Beck AT, Steer RA. Manual for Beck Scale for Suicide Ideation. San Antonio, TX: The Psychological Corporation; 1991.
17. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R, Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
18. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with Female Orgasmic Disorder and in women with Hypoactive Sexual Desire Disorder. J Sex Marital Ther 2003;29:39-46.
19. Revicki D, Margolis MK, Bush EN, DeRogatis L, Hanes V. Content validity of the Female Sexual Function Index (FSFI) in pre- and post-menopausal women with Hypoactive Sexual Desire Disorder (HSDD). J Sex Med 2011;8:2237-45.
20. DeRogatis LR, Clayton AH, Goldstein A, Lewis-D'Agostino D, Wunderlich G, Cotton D. eDiary and Female Sexual Distress Scale in evaluating distress in Hypoactive Sexual Desire Disorder (HSDD). J Sex Res 2010;15:1-8.
21. Gerstenberger EP, Rosen RC, Brewer JV, Meston CM, Brotto LA, Wiegel M, Sand M. Sexual desire and the Female Sexual Function Index (FSFI): A sexual desire cutpoint for clinical interpretation of the FSFI in women with and without Hypoactive Sexual Desire Disorder. J Sex Med 2010;7:3096-103.
22. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20.
23. Jolly E, Clayton A, Thorp J, Nappi R, Kimura T, Sand M, Pyke R. Efficacy of flibanserin 100mgqhs in premenopausal women with Hypoactive Sexual Desire Disorder: Responder analysis. J Sex Med 2010;7(3 suppl):122.
24. Bancroft J, Graham CA, Janssen E, Sanders SA. The dual control model: Current status and future directions. J Sex Res 2009;46:121-42.
25. Allers KA, Dremencov E, Ceci A, Flik G, Ferger B, Cremers TI, Ittrich C, Sommer B. Acute and repeated flibanserin administration in female rats modulates monoamines differentially accross brain areas: A microdialysis study. J Sex Med 2010;7:1757-67.
26. Gelez H, Allers KA, Sommer B, Guiliano F. Chronic flibanserin treatment increases solicitations in the female rat. J Sex Med 2010;7(3 suppl):118.
27. Aubert Y, Converse A, Sommer B, Allers KA, Abbott D. Comparison of flibanserin with the 5-HT1A agonist (+)-8-OH-DPAT in affecting interactions between male-female marmoset pairs. J Sex Med 2009;6(5 suppl):422.
28. Clayton AH, Dennerstein L, Pyke R, Sand M. Flibanserin: A potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women. Womens Health (Lond Engl) 2010;6:639-53.